In A549 lung cancer cells treated with 100 μM C3G, AMPK/mTOR, an important energy metabolism-related pathway, was significantly altered, AMPK was activated, and its downstream target gene mTOR was significantly downregulated (Fig. 5a). The gene discussed is MTOR; the disease is lung carcinoma.